Dr. Thomas Cerillo is a Bronxville, New York based male podiatrist who is specialized in Podiatry. Active license number of Dr. Thomas Cerillo for Podiatry is N002655 in New York. Dr. Thomas Cerillo is qualified with a Doctor of Podiatric Medicine (D.P.M.) degree, licensed by the state, and practicing within the scope of that license. He diagnose and treat foot diseases and deformities. He can perform medical, surgical and other operative procedures, prescribe corrective devices and prescribe and administer drugs and physical therapy.
Complete Profile:
Dr. Thomas Cerillo speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Podiatrist
Credentials:
D.P.M.
Gender:
Male
Practice Address:
116 Kraft Avenue, Bronxville, New York, 10708-4182
Phone:
914-337-1251
Fax:
914-793-7473
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1073611836
NPI Enumeration Date:
20 Sep, 2006
NPI Last Update On:
29 May, 2008
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Thomas Cerillo are as mentioned below.
License Number
Specialization
State
Status
N002655
Podiatry
New York
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Po Box 188, Bronxville, New York
Zip:
10708-4182
Phone Number:
--
Fax Number:
--
Patients can reach Dr. Thomas Cerillo at 116 Kraft Avenue, Bronxville, New York or can call to book an appointment on 914-337-1251. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.